APA (7th ed.) Citation

Ahodantin, J., Li, F., Su, L., Guo, H., Cuconati, A., & Walker, J. M. (2024). Modeling HBV Infection and Therapy in Immunodeficient NOD- Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (FAH) Knockout Mice with Human Chimeric Liver. Hepatitis B Virus: Methods and Protocols, 2837, 199-206. https://doi.org/10.1007/978-1-0716-4027-2

Chicago Style (17th ed.) Citation

Ahodantin, James, Feng Li, Lishan Su, Haitao Guo, Andrea Cuconati, and John M. Walker. "Modeling HBV Infection and Therapy in Immunodeficient NOD- Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (FAH) Knockout Mice with Human Chimeric Liver." Hepatitis B Virus: Methods and Protocols 2837 (2024): 199-206. https://doi.org/10.1007/978-1-0716-4027-2.

MLA (9th ed.) Citation

Ahodantin, James, et al. "Modeling HBV Infection and Therapy in Immunodeficient NOD- Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (FAH) Knockout Mice with Human Chimeric Liver." Hepatitis B Virus: Methods and Protocols, vol. 2837, 2024, pp. 199-206, https://doi.org/10.1007/978-1-0716-4027-2.